39 results on '"Kundu, Madan G"'
Search Results
2. Survival Tree Provides Individualized Estimates of Survival After Lung Transplant
3. An introduction to the determination of the probability of a successful trial: Frequentist and Bayesian approaches
4. Impact of the adjustment of stratification factors on time-to-event analyses
5. Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer
6. Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial
7. Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: meta-analyses of published studies
8. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
9. Supplementary Tables 1-4 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
10. Data from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
11. Supplementary Appendix 1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
12. Supplementary Figure S1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
13. Longitudinal Functional Models with Structured Penalties
14. A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
15. Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpoints
16. Recipient Survival after Orthotopic Liver Transplantation: Interpretable Machine Learning Survival Tree Algorithm for Patient-Specific Outcomes
17. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
18. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
19. Analysis of the potential risk of central intravenous lines and/or total parenteral nutrition with ventriculoatrial shunts
20. Final Results of a Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
21. Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials
22. Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials: by Meinhard Kieser, (Springer Series in Pharmaceutical Statistics, 2020.).
23. Simulation free estimation of the correlation matrix in MaxCombo test and comments on “Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group”
24. Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)
25. Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Real-Time PCR: A Predictive Tool for Contamination of the Hospital Environment
26. Closed-Form Approximation of Correlation Matrix Among Fleming Harrington Test Statistics in MaxCombo Test: Comments on "Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group".
27. Statistics and machine learning methods for EHR data – from data extraction to data analytics
28. Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
29. On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design
30. Comments on “Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects” by Jose Jimenez, Viktoriya Stalbovskaya, and Byron Jones. Pharm Stat. 18:287‐303, 2019, DOI: 10.1002/pst.1923
31. Corrigendum to “Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies” [Contemp. Clin. Trials 53 (2017) 20–28]
32. Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
33. Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies
34. Adaptive penalties for generalized Tikhonov regularization in statistical regression models with application to spectroscopy data
35. Longitudinal functional models with structured penalties
36. Phase 1 dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors.
37. Adaptive penalties for generalized Tikhonov regularization in statistical regression models with application to spectroscopy data.
38. Methicillin-Resistant Staphylococcus aureus(MRSA) Nasal Real-Time PCR: A Predictive Tool for Contamination of the Hospital Environment
39. Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.